ArticleInternational journal of retina and vitreous2026
Vitamin D supplementation in diabetic retinopathy: an optical coherence tomography angiography study of changes in macular perfusion.
Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObservational studies suggested a link between vitamin D deficiency (VDD) and diabetic retinopathy (DR). However, evidence from interventional studies on possible effects of VDD correction on retinal microvasculature in DR is scarce.
methodsThis single-arm exploratory interventional study included 60 eyes from 30 patients with VDD and type 2 diabetes mellitus (DM), without DR or with mild or moderate non-proliferative DR (NPDR). Participants received oral vitamin D3 (50,000 IU/week for 8 weeks) followed by a daily maintenance dose (800 IU). Optical coherence tomography angiography (OCTA) imaging was performed before and three months after vitamin D repletion. Outcome measures were macular perfusion parameters and best-corrected visual acuity (BCVA). Linear mixed effects models were used to evaluate the association between changes in outcome measures with change in serum 25(OH)D3 levels.
resultsThe mean serum 25(OH)D3 level increased significantly post-intervention (14.20 ± 4.04 to 55.82 ± 6.79 ng/mL; p < 0.001), and VDD was corrected in all patients. A small improvement was noted in BCVA with marginal statistical significance (0.12 ± 0.13 to 0.10 ± 0.13 Logarithm of the Minimum Angle of Resolution; p = 0.051). Other than a small reduction in parafoveal superficial vessel density at the superior quadrant (-3.23 ± 6.66%, p = 0.011), none of the perfusion metrics had changed three months after VDD correction. Linear models yielded no association between changes in serum 25(OH)D3 levels and alterations in BCVA or OCTA macular perfusion metrics.
conclusionsBased on this non-controlled interventional study, short-term effects of VDD correction in people with DM without severe DR does not appear to significantly influence the visual acuity or macular perfusion profile on OCTA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.